NOT-TR-23-013: Notice of Termination of RFA-TR-22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)

Notice of Termination of RFA-TR-22-013 Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)

Notice Number:

NOT-TR-23-013

Key Dates

Release Date:

April 20, 2023

Related Announcements

RFA-TR-22-013 - "Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)

RFA-TR-23-011 - Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)

Issued by

National Center for Advancing Translational Sciences (NCATS)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

Effective immediately, the Funding Opportunity Announcement RFA-TR-22-013 "Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed) is terminated. Applications submitted to RFA-TR-22-013 will not be reviewed. NIH has reissued this Funding Opportunity Announcement as RFA-TR-23-011 "Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)."

Inquiries

Please direct all inquiries to:

Steven Pittenger, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-5810
Email: [email protected]